Senzime AB (publ) (SNZZF)
OTCMKTS · Delayed Price · Currency is USD
0.6500
0.00 (0.00%)
Oct 22, 2025, 8:00 PM EDT
Senzime AB Revenue
Senzime AB had revenue of 25.70M SEK in the quarter ending June 30, 2025, with 72.25% growth. This brings the company's revenue in the last twelve months to 80.64M, up 71.41% year-over-year. In the year 2024, Senzime AB had annual revenue of 58.48M with 63.55% growth.
Revenue (ttm)
80.64M SEK
Revenue Growth
+71.41%
P/S Ratio
11.71
Revenue / Employee
1.49M SEK
Employees
54
Market Cap
99.28M USD
Revenue Chart
* This company reports financials in SEK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 58.48M | 22.72M | 63.55% |
| Dec 31, 2023 | 35.75M | 21.72M | 154.77% |
| Dec 31, 2022 | 14.03M | 3.05M | 27.81% |
| Dec 31, 2021 | 10.98M | 1.64M | 17.60% |
| Dec 31, 2020 | 9.34M | 2.63M | 39.13% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| Nuo Therapeutics | 1.95M |
| Northwest Biotherapeutics | 1.09M |
Senzime AB News
- 16 days ago - Senzime Launches EMGINE, The Next-Generation Software Suite Advancing Neuromuscular Monitoring - Accesswire
- 21 days ago - Senzime Welcomes New European Pediatric Guidelines Recommending EMG-Based Neuromuscular Monitoring - Accesswire
- 4 weeks ago - Senzime AB (publ) (SNZZF) Senzime AB (publ) Presents at Pareto Securities' 16th Annual Healthcare Conference 2025 - Slideshow - Seeking Alpha
- 5 weeks ago - Senzime Awarded Contract to Supply the U.S. Department of Defense and Walter Reed National Military Medical Center - Accesswire
- 6 weeks ago - Senzime to Present at Pareto Securities' 16th Annual Healthcare Conference - Accesswire
- 6 weeks ago - Senzime Launches Integration with Mindray Patient Monitors - Accesswire
- 6 weeks ago - Senzime Welcomes New Japanese Guidelines on Neuromuscular Monitoring - Accesswire
- 6 weeks ago - Senzime to Present at the European Growth Virtual Investor Conference on September 11 - Accesswire